|Bid||120.30 x 1300|
|Ask||122.52 x 900|
|Day's Range||121.23 - 127.36|
|52 Week Range||66.81 - 163.08|
|Beta (5Y Monthly)||0.97|
|PE Ratio (TTM)||554.21|
|Earnings Date||Nov 02, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||147.00|
STAAR Surgical (STAA) has been struggling lately, but the selling pressure may be coming to an end soon.
LAKE FOREST, Calif., October 20, 2021--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended October 1, 2021 on Wednesday, November 3, 2021 after the market close.
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]